14159, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 202,130 shares at $76.62 ($15.9M) on 2018-12-03, disclosed to the SEC on 2018-12-03.
Open-market sale of $15.9M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.62 | 4 | $306 | 0.0% |
| 2 | $76.62 | 247 | $19K | 0.1% |
| 3 | $76.62 | 38 | $3K | 0.0% |
| 4 | $76.62 | 6 | $460 | 0.0% |
| 5 | $76.62 | 1 | $77 | 0.0% |
| 6 | $77.52 | 5,005 |
| $388K |
| 2.4% |
| 7 | $77.52 | 32,598 | $2.5M | 15.9% |
| 8 | $77.52 | 863 | $67K | 0.4% |
| 9 | $77.52 | 38 | $3K | 0.0% |
| 10 | $77.52 | 500 | $39K | 0.2% |
| 11 | $77.52 | 559 | $43K | 0.3% |
| 12 | $78.05 | 89,047 | $7.0M | 43.8% |
| 13 | $78.05 | 104 | $8K | 0.1% |
| 14 | $78.05 | 1,367 | $107K | 0.7% |
| 15 | $78.05 | 1,526 | $119K | 0.8% |
| 16 | $78.05 | 2,357 | $184K | 1.2% |
| 17 | $78.05 | 13,671 | $1.1M | 6.7% |
| 18 | $80.09 | 765 | $61K | 0.4% |
| 19 | $80.09 | 6,856 | $549K | 3.5% |
| 20 | $80.09 | 1,182 | $95K | 0.6% |
| 21 | $80.09 | 52 | $4K | 0.0% |
| 22 | $80.09 | 685 | $55K | 0.3% |
| 23 | $80.09 | 44,659 | $3.6M | 22.5% |
| Total | $78.49 avg | 202,130 | $15.9M | 100% |
| Filing → |
| GHDX | SELL | 2019-01-14 | $2.8M | — | Filing → |
| ACAD | BUY | 2018-12-04 | $200.0M | — | Filing → |
| GHDX | SELL | 2018-11-13 | $6.6M | — | Filing → |